August 2008 Oncology News International

News
Article

Cover Story

  • High cost of biologics takes a toll on hem/onc practices
  • FDA cracks down on counterfeit cancer cure products

DEPARTMENTS

Focus on Breast Cancer

  • Mastectomy rates for early breast cancer are on the upswing at one Mayo Clinic
  • Is breast MRI primed for widespread use as a high-risk screening tool?
  • Vantage Point: Risk factors will guide the imaging paradigm

Focus on Lung Cancer

  • Anti-IGF-1R antibody plus chemo active in advanced non-small-cell lung cancer

News & Analysis

  • Oncologic drug safety: Separating fact from fiction

Focus on Prostate Cancer

  • Dual antiangiogenic therapy plus chemo is active in advanced prostate cancer

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content